CatalystWireBeta

Holding(s) in Company

In brief · summary, not quotable

JPMorgan Chase & Co., through its subsidiary J.P. Morgan Securities PLC, has acquired a notifiable interest in Advanced Medical Solutions Group PLC, now holding a total of 5.245538% of the voting rights. This comprises 4.324922% directly attached to shares and 0.920616% through financial instruments, specifically cash-settled equity swaps with various expiration dates up to November 2027. The acquisition crossed the notification threshold on October 9, 2026, with the issuer being notified on October 13, 2026.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your AMS notes

Issuer Details

ISIN

GB0004536594

Issuer Name

ADVANCED MEDICAL SOLUTIONS GROUP PLC

UK or Non-UK Issuer

UK

Reason for Notification

An acquisition or disposal of voting rights

Details of person subject to the notification obligation

Name

JPMorgan Chase & Co.

City of registered office (if applicable)

Country of registered office (if applicable)

US

Details of the shareholder

NameCity of registered officeCountry of registered office

J.P. Morgan Securities PLC

Date on which the threshold was crossed or reached

09-Oct-2026

Date on which Issuer notified

13-Oct-2026

  • Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A)% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)Total of both in % (8.A + 8.B)Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached4.3249220.9206165.24553811519416
Position of previous notification (if applicable)Below minimum thresholdBelow minimum thresholdBelow minimum threshold
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible)Number of direct voting rights (DTR5.1)Number of indirect voting rights (DTR5.2.1)% of direct voting rights (DTR5.1)% of indirect voting rights (DTR5.2.1)
GB000453659494977104.324922
Sub Total 8.A94977104.324922%
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrumentExpiration dateExercise/conversion periodNumber of voting rights that may be acquired if the instrument is exercised/converted% of voting rights

Sub Total 8.B1

  • Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial instrumentExpiration dateExercise/conversion periodPhysical or cash settlementNumber of voting rights% of voting rights
Cash-settled Equity Swap15/10/202615/10/2026Cash299910.013657
Cash-settled Equity Swap03/11/202603/11/2026Cash100740.004587
Cash-settled Equity Swap27/11/202627/11/2026Cash89430.004072
Cash-settled Equity Swap02/12/202602/12/2026Cash203080.009248
Cash-settled Equity Swap05/01/202705/01/2027Cash2645780.120479
Cash-settled Equity Swap15/02/202715/02/2027Cash69300.003156
Cash-settled Equity Swap02/03/202702/03/2027Cash368310.016772
Cash-settled Equity Swap20/04/202720/04/2027Cash113400.005164
Cash-settled Equity Swap19/05/202719/05/2027Cash10920000.497258
Cash-settled Equity Swap27/05/202727/05/2027Cash1470870.066978
Cash-settled Equity Swap14/06/202714/06/2027Cash179650.008181
Cash-settled Equity Swap02/07/202702/07/2027Cash353360.016091
Cash-settled Equity Swap05/07/202705/07/2027Cash3137300.142862
Cash-settled Equity Swap03/08/202703/08/2027Cash24260.001105
Cash-settled Equity Swap23/08/202723/08/2027Cash4990.000227
Cash-settled Equity Swap25/08/202725/08/2027Cash60080.002736
Cash-settled Equity Swap02/11/202702/11/2027Cash39800.001812
Cash-settled Equity Swap02/12/202702/12/2027Cash12530.000571
Cash-settled Equity Swap04/10/202704/10/2027Cash42110.001918
Cash-settled Equity Swap15/11/202715/11/2027Cash62840.002862
Cash-settled Equity Swap24/11/202724/11/2027Cash19320.000880
Sub Total 8.B220217060.920616%
  • Information in relation to the person subject to the notification obligation
Ultimate controlling personName of controlled undertaking% of voting rights if it equals or is higher than the notifiable threshold% of voting rights through financial instruments if it equals or is higher than the notifiable thresholdTotal of both if it equals or is higher than the notifiable threshold
JPMorgan Chase & Co.J.P. Morgan Securities PLC3.5984794.519095%
JPMorgan Chase & Co.J.P. Morgan SE

In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

If date does not apply, explain below

Additional Information

Chain of controlled undertakings:

JPMorgan Chase & Co.

JPMorgan Chase Bank, National Association (100%)

J.P. Morgan International Finance Limited (100%)

J.P. Morgan Capital Holdings Limited (100%)

J.P. Morgan Securities PLC (100%)

JPMorgan Chase & Co.

JPMorgan Chase Bank, National Association (100%)

J.P. Morgan International Finance Limited (100%)

J.P. Morgan SE (100%)

Date of Completion

13-Oct-2026

Place Of Completion

London

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note